Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Absence of a High Level of Duplication of the Plasmepsin II Gene in Africa.

Robert MG, Foguim Tsombeng F, Gendrot M, Mosnier J, Amalvict R, Benoit N, Torrentino-Madamet M, Pradines B; French National Reference Centre for Imported Malaria Study Group .

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00374-18. doi: 10.1128/AAC.00374-18. Print 2018 Nov.

PMID:
30181370
2.

Plasmodium falciparum Recrudescence Two Years after Treatment of an Uncomplicated Infection without Return to an Area Where Malaria Is Endemic.

Malvy D, Torrentino-Madamet M, L'Ollivier C, Receveur MC, Jeddi F, Delhaes L, Piarroux R, Millet P, Pradines B.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01892-17. doi: 10.1128/AAC.01892-17. Print 2018 Feb.

3.

K13-Propeller Polymorphisms in Plasmodium falciparum Isolates from Patients in Mayotte in 2013 and 2014.

Torrentino-Madamet M, Collet L, Lepère JF, Benoit N, Amalvict R, Ménard D, Pradines B.

Antimicrob Agents Chemother. 2015 Dec;59(12):7878-81. doi: 10.1128/AAC.01251-15. Epub 2015 Sep 28.

4.

Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013.

Torrentino-Madamet M, Fall B, Benoit N, Camara C, Amalvict R, Fall M, Dionne P, Ba Fall K, Nakoulima A, Diatta B, Diemé Y, Ménard D, Wade B, Pradines B.

Malar J. 2014 Dec 4;13:472. doi: 10.1186/1475-2875-13-472.

5.

Plasmodium falciparum infection-induced changes in erythrocyte membrane proteins.

Fontaine A, Bourdon S, Belghazi M, Pophillat M, Fourquet P, Granjeaud S, Torrentino-Madamet M, Rogier C, Fusai T, Almeras L.

Parasitol Res. 2012 Feb;110(2):545-56. doi: 10.1007/s00436-011-2521-2. Epub 2011 Jul 9.

PMID:
21744020
6.

Global response of Plasmodium falciparum to hyperoxia: a combined transcriptomic and proteomic approach.

Torrentino-Madamet M, Alméras L, Desplans J, Le Priol Y, Belghazi M, Pophillat M, Fourquet P, Jammes Y, Parzy D.

Malar J. 2011 Jan 11;10:4. doi: 10.1186/1475-2875-10-4.

7.

Microaerophilic respiratory metabolism of Plasmodium falciparum mitochondrion as a drug target.

Torrentino-Madamet M, Desplans J, Travaillé C, James Y, Parzy D.

Curr Mol Med. 2010 Feb;10(1):29-46. Review.

PMID:
20205678
8.

Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria.

Parquet V, Briolant S, Torrentino-Madamet M, Henry M, Almeras L, Amalvict R, Baret E, Fusaï T, Rogier C, Pradines B.

Antimicrob Agents Chemother. 2009 Jun;53(6):2248-52. doi: 10.1128/AAC.01462-08. Epub 2009 Mar 23.

9.

Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.

Pradines B, Torrentino-Madamet M, Fontaine A, Henry M, Baret E, Mosnier J, Briolant S, Fusai T, Rogier C.

Antimicrob Agents Chemother. 2007 Jul;51(7):2654-5. Epub 2007 May 14. No abstract available.

10.

Polymorphism in plasmodium falciparum drug transporter proteins and reversal of in vitro chloroquine resistance by a 9,10-dihydroethanoanthracene derivative.

Millet J, Alibert S, Torrentino-Madamet M, Rogier C, Santelli-Rouvier C, Bigot P, Mosnier J, Baret E, Barbe J, Parzy D, Pradines B.

Antimicrob Agents Chemother. 2004 Dec;48(12):4869-72.

11.

Dihydroethanoanthracene derivatives as in vitro malarial chloroquine resistance reversal agents.

Millet J, Torrentino-Madamet M, Alibert S, Rogier C, Santelli-Rouvier C, Mosnier J, Baret E, Barbe J, Parzy D, Pradines B.

Antimicrob Agents Chemother. 2004 Jul;48(7):2753-6.

Supplemental Content

Loading ...
Support Center